Measurements of auto-antibodies to α-synuclein in the serum and cerebral spinal fluids of patients with Parkinson's disease

Keyphrases

• Alpha-synuclein (α-syn) 100%
• Cerebrospinal Fluid 100%
• Autoantibodies 100%
• Patients with Parkinson's Disease 100%
• Healthy Controls 33%
• Antibody Level 33%
• Parkinson Patients 33%
• Parkinson's Disease 16%
• Synucleinopathy 16%
• N-terminal Modification 8%
• Recombinant 8%
• Amino Acids 8%
• Montreal Cognitive Assessment (MoCA) 8%
• Serum Samples 8%
• Enzyme-linked Immunosorbent Assay (ELISA) 8%
• Serum Levels 8%
• Clinical Correlation 8%
• Antibody Targeting 8%
• Human Samples 8%
• Clinical Heterogeneity 8%
• Phosphorylated tau 8%
• Lumbar Puncture 8%
• C-terminal Region 8%
• Hemoglobin Level 8%
• C-terminal Truncation 8%
• Total tau 8%
• Editorial Highlight 8%

Biochemistry, Genetics and Molecular Biology

• Autoantibodies 100%
• Synuclein 100%
• Tau 16%
• C-Terminus 16%
• N-Terminus 8%
• Amino Acids 8%
• Enzyme 8%
• Blood Level 8%
• Hemoglobin Blood Level 8%
• Amyloid Protein 8%

Immunology and Microbiology

• Autoantibodies 100%
• Cerebrospinal Fluid 100%
• Carboxy Terminal Sequence 16%
• Enzyme-Linked Immunosorbent Assay 8%
• Blood Level 8%
• Amino Terminal Sequence 8%
• Hemoglobin Blood Level 8%
• Amino Acid 8%